Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Core 60/40 Balanced Allocation ETF (NY:AOR)

64.71 -0.05 (-0.08%)
Official Closing Price Updated: 8:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Core 60/40 Balanced Allocation ETF

Uber Delivers Solid Earnings, But Tepid Q4 Guidance Sends Stock Lower ↗
Via Stocktwits
News headline image
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates ↗
The company noted that it is on track to deliver about $7.2 billion in overall anticipated net cost savings by the end of 2027. 
Via Stocktwits
Topics Artificial Intelligence World Trade
News headline image
American Airlines Names Aviation Veteran Nathaniel Pieper As Chief Commercial Officer ↗
American Airlines said that Pieper joins the company after serving as oneworld CEO since April 2024. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm ↗
BofA analyst Alexander Perry raised the firm's price target on Polaris to $70 from $60 after the company agreed to sell a majority stake in Indian Motorcycle to California-headquartered private equity... 
Via Stocktwits
Ford CEO Jim Farley Reportedly Expects US EV Demand To Decline Sharply – Here’s Why ↗
Via Stocktwits
Acadia Healthcare Stock Surges Pre-Market After Activist Hedge Fund Reportedly Seeks Board Revamp ↗
Via Stocktwits
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study ↗
Via Stocktwits
BWXT Shares Climb On Department Of Energy’s $1.5B Contract ↗
Via Stocktwits
RH Stock Sees Slew Of Downgrades, Price Target Cuts From Wall Street As Trump Tariffs Bite ↗
Via Stocktwits
Topics Government
News headline image
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study ↗
The company said on Wednesday that its drug did not meet the primary endpoint of the trial primarily due to a higher-than-expected placebo response rate. 
Via Stocktwits
News headline image
Acadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage Study ↗
The company noted that the safety and tolerability of intranasal Carbetocin were consistent with those observed in previous clinical trials. 
Via Stocktwits
Legend Biotech Considering Second Listing Outside US: Report ↗
Via Stocktwits
News headline image
Hertz Expands Program Allowing Prolonged 3-Day Test Drives Before Vehicle Purchase To Over 100 Cities ↗
Consumers can test the vehicles for up to three days before purchasing at a low daily rate. 
Via Stocktwits
Schrödinger Discontinues Clinical Program After Two Patient Deaths ↗
Via Stocktwits
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ ↗
Via Stocktwits
News headline image
Baxter Appoints Andrew Hider To Succeed Jose Almeida As CEO: Retail Sentiment Falters ↗
Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), Baxter said. 
Via Stocktwits
News headline image
60/40 Portfolio Bounces Back From 2022 Slump: Is It The Right Investment Strategy For 2024? ↗
The traditional 60/40 investment portfolio recorded 13% growth in 2023, its third-best year since 2008. Investors ponder if favorable conditions in H2 of 2023 will continue in 2024. 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS